‘Absolutely staggering’: Results from experimental drug trial to prevent Parkinson’s disease

For the first time, the Australian-led trial has found evidence that an experimental drug could lessen inflammation in the brains of people at high risk of Parkinson’s, potentially slowing or even stopping its development.